Professor Lixin Xie, a member of the Chinese Academy of Engineering, led a dry eye treatment study at the Qingdao Eye Hospital. The treatment, known as HBM9036, was led by a Chinese sponsor known as Harbour Biomed—a partner to Korean venture HanAll Biopharma. The...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok